Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The activation of human factor IX.

B Osterud, K Laake, H Prydz

    Thrombosis Et Diathesis Haemorrhagica
    |June 30, 1975
    PubMed
    Summary

    Factor XIa and kallikrein activate factor IX, a crucial protein in blood clotting. This activation process, studied using gel electrophoresis, reveals changes in factor IX

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Lectin Stimulation of Tissue Thromboplastin Activity in Human Monocytes in vitro.

    Thrombosis and haemostasis·2019
    Same author

    The key roles of complement and tissue factor in Escherichia coli-induced coagulation in human whole blood.

    Clinical and experimental immunology·2015
    Same author

    Procoagulant and proinflammatory effects of red blood cells on lipopolysaccharide-stimulated monocytes.

    Journal of thrombosis and haemostasis : JTH·2015
    Same author

    Alterations in markers of coagulation and fibrinolysis in patients with Paroxysmal Nocturnal Hemoglobinuria before and during treatment with eculizumab.

    Thrombosis research·2015
    Same author

    Circadian rhythms of hemostatic factors in tetraplegia: a double-blind, randomized, placebo-controlled cross-over study of melatonin.

    Spinal cord·2015
    Same author

    The partial thromboplastin time: reply.

    Journal of thrombosis and haemostasis : JTH·2014

    Area of Science:

    • Biochemistry
    • Hematology
    • Protein Chemistry

    Background:

    • Factor IX is a key component of the intrinsic pathway of blood coagulation.
    • Understanding factor IX activation is essential for comprehending hemostasis and thrombosis.

    Purpose of the Study:

    • To investigate the specific activators of human plasma-derived factor IX.
    • To characterize the molecular changes occurring during factor IX activation.

    Main Methods:

    • Purification of factor IX from human plasma.
    • Enzymatic activation assays using purified factor IX.
    • Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) for molecular weight determination.

    Main Results:

    • Factor XIa and kallikrein were identified as separate activators of factor IX.
    • Activated factor IX (factor IXa) exhibited a reduced molecular weight (42-45 kDa) compared to native factor IX (70 kDa).
    • Factor XIa-mediated activation required calcium ions; other factors like factor VII or Russell's viper venom did not activate factor IX under tested conditions.
    • Trypsin demonstrated activation, while plasmin showed inactivation of factor IX.

    Conclusions:

    • Factor XIa and kallikrein are physiological activators of factor IX.
    • Activation involves a significant conformational or structural change, indicated by the molecular weight reduction.
    • Calcium ions play a critical role in factor XIa-dependent factor IX activation.

    Related Experiment Videos